Heartflow CMO sells 19,682 shares at $50.15
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Heartflow, Inc. (HTFL) reported that Chief Medical Officer Campbell Rogers exercised stock options for 13,179 shares of common stock on September 18, 2026 at exercise prices of $8.33 and $2.22 per share and sold 19,682 shares at $50.15 per share, all effected under a Rule 10b5-1 trading plan adopted on June 16, 2026.
After these transactions, Rogers continued to hold shares indirectly through several personal and family trusts, including 22,615, 46,159, 26,012 and 50,754 shares in separate trust accounts.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
5 txns
Insider
Rogers Campbell
Role
Chief Medical Officer
Sold
19,682 shs ($987K)
Approx. gross sale proceeds
$987K
Approx. exercise cost
$105K
Share of Position Sold
19.8%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F3 | 12,329 | $0.00 | $0.00 |
| Exercise | Stock Option F1, F4 | 850 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 12,329 | $8.33 | $103K |
| Exercise | Common Stock F1 | 850 | $2.22 | $2K |
| Sale | Common Stock F2 | 19,682 | $50.15 | $987K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option — 102,239 options (Direct);
Common Stock — 79,956 shares (Direct);
Common Stock — 22,615 shares (Indirect, By Campbell Rogers 2019 Irrevocable Trust);
Common Stock — 46,159 shares (Indirect, By CR Asset Protection Trust of 2023);
Common Stock — 26,012 shares (Indirect, By Spouse's Trust);
Common Stock — 50,754 shares (Indirect, By The Campbell Rogers Revocable Trust)
Holdings Before and After:
Stock Option, 115,418 to 102,239 options (Direct);
Common Stock, 86,459 to 79,956 shares (Direct)
Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (4)
- F1. The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.
- F2. Includes the sale of 6,503 shares of common stock held and the option exercise and sale of 13,179 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.
- F3. These stock options are fully exercisable.
- F4. The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.
Key Figures
Options exercised: 13,179 shares
Sale volume: 19,682 shares
Sale price: $50.15 per share
+5 more
8 metrics
Options exercised
13,179 shares
Common stock acquired upon option exercises on September 18, 2026
Sale volume
19,682 shares
Common stock sold on September 18, 2026
Sale price
$50.15 per share
Price for 19,682 shares of common stock sold
Option exercise price
$8.33 per share
Exercise price for 12,329 shares of common stock
Option exercise price
$2.22 per share
Exercise price for 850 shares of common stock
Indirect holding – Campbell Rogers 2019 Irrevocable Trust
22,615 shares
Indirect common stock ownership reported through this trust
Indirect holding – CR Asset Protection Trust of 2023
46,159 shares
Indirect common stock ownership reported through this trust
Indirect holding – The Campbell Rogers Revocable Trust
50,754 shares
Indirect common stock ownership reported through this trust
Key Terms
Rule 10b5-1 Trading Plan, stock options, Irrevocable Trust, Asset Protection Trust
4 terms
Rule 10b5-1 Trading Plan regulatory
"were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
stock options financial
"These stock options are fully exercisable."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
Irrevocable Trust financial
"By Campbell Rogers 2019 Irrevocable Trust"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
Asset Protection Trust financial
"By CR Asset Protection Trust of 2023"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did HTFL’s Chief Medical Officer report on September 18, 2026?
Campbell Rogers reported exercising stock options for 13,179 shares of Heartflow common stock and selling 19,682 shares at $50.15 per share on September 18, 2026, in a series of related transactions.
At what prices were the HTFL stock options exercised by the Chief Medical Officer?
The reported stock options were exercised for Heartflow common stock at exercise prices of $8.33 per share for 12,329 shares and $2.22 per share for 850 shares on September 18, 2026.
Were the HTFL insider transactions made under a Rule 10b5-1 trading plan?
Yes. The option exercise and related sale were effected pursuant to a Rule 10b5-1 trading plan adopted by Campbell Rogers on June 16, 2026, as stated in the footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
